President Donald Trump announced Tuesday that generic drugs imported into the U.S. will remain exempt from tariffs for two years before facing duties of up to 200%, as his administration seeks to push pharmaceutical manufacturing back to the U.S. Beginning August 1, imported generic medicines will continue to face a 0% tariff for two years before duties increase to 100% for one year and then 200%, according to a post by Trump on Truth Social.

Tariff Schedule and Objectives

Trump said the policy is designed to encourage drugmakers to relocate generic pharmaceutical manufacturing to the U.S., with companies that fail to build domestic plants during the transition period facing penalties. "This is done in order to RESHORE Generic Pharmaceutical Production into America," Trump added. Generic drugs account for more than 90% of prescriptions filled in the U.S., according to the Food and Drug Administration.

Expansion of Manufacturing Strategy

The generic drug policy expands on the administration’s earlier strategy for branded and patented medicines, under which major drugmakers agreed to lower prices in exchange for temporary tariff exemptions. In December, nine drugmakers, including Bristol Myers Squibb Co., Merck & Co. Inc., Novartis AG, Amgen Inc. and GSK plc, committed to bringing U.S. drug prices more in line with those in other developed countries.

Johnson & Johnson committed to new manufacturing investments under those agreements earlier this year, while Merck pledged more than $70 billion toward domestic research and production. Trump said pharmaceutical facilities are now being built across the U.S. "at a level never seen before."

The US Latino economy reached $4.4 trillion in 2024, ranking as the fourth-largest economy globally and the fastest-growing among the world's largest economies. This finding comes from the 2026 LDC U.S. Latino Economic Impact Report: Part One, commissioned by the Latino Donor Collaborative and developed by the L. William Seidman Research Institute at Arizona State University's W. P. Carey School of Business. The report highlights that US Latinos accounted for 28.2% of US economic growth in 2024, despite representing about one-fifth of the nation's population.

Latino households generated $3.4 trillion in gross domestic income, while household consumption reached $2.8 trillion. This consumption figure positions the US Latino market as the third-largest consumer market in the world, larger than those of Germany and India. Since 2019, inflation-adjusted Latino household consumption has grown nearly three times faster than that of non-Latino households.

Key Economic Indicators

The report provides a detailed breakdown of the economic contributions of the US Latino community in 2024:

Demographic and Business Growth

By 2025, US Latinos accounted for 92.6% of all new households formed in the country. Latino-owned employer businesses totaled 5.7 million in 2022. A younger population concentrated in prime working years continues to strengthen labor force participation and business creation nationwide. The report notes that Americans of Mexican descent represent 57% of the US Latino population and generate $2.3 trillion in economic output.

Regional Impact

The economic influence extends beyond traditional population centers. California's Latino economy reached $1.1 trillion and Texas reached $820 billion in 2024. The report also highlights growing economic influence in states including North Carolina and New Jersey, where Latino population growth is expanding local workforces, businesses, and consumer markets.

"Latino household consumption is expanding at nearly three times the pace of the rest of the US consumer base," said Sol Trujillo, chairman and co-founder of the Latino Donor Collaborative. "Any company, investor, or policymaker assessing where demand will come from over the next decade has the answer in front of them."